Clarity Pharmaceuticals Ltd (CU6.AX)
AUD 1.75
(8.05%)
AUD 1.75
(8.05%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 56.3 Million AUD | 56.13% |
| 2023 | 36.06 Million AUD | 19.06% |
| 2022 | 30.29 Million AUD | 124.48% |
| 2021 | 13.49 Million AUD | 37.29% |
| 2020 | 9.82 Million AUD | 53.89% |
| 2019 | 6.38 Million AUD | 52.95% |
| 2018 | 4.17 Million AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 11.8 Million AUD | -36.33% |
| 2024 Q3 | 16.34 Million AUD | -30.64% |
| 2024 FY | 56.15 Million AUD | 55.71% |
| 2024 Q2 | 23.56 Million AUD | 99.57% |
| 2024 Q4 | 16.34 Million AUD | 0.0% |
| 2023 Q4 | 18.54 Million AUD | 99.43% |
| 2023 FY | 36.06 Million AUD | 19.06% |
| 2023 Q3 | 9.29 Million AUD | -46.92% |
| 2023 Q2 | 17.51 Million AUD | 99.46% |
| 2023 Q1 | 8.78 Million AUD | -35.97% |
| 2022 Q1 | 8.27 Million AUD | 14.24% |
| 2022 FY | 30.29 Million AUD | 124.48% |
| 2022 Q4 | 13.71 Million AUD | 99.51% |
| 2022 Q3 | 6.87 Million AUD | -56.68% |
| 2022 Q2 | 15.87 Million AUD | 91.91% |
| 2021 FY | 13.49 Million AUD | 37.29% |
| 2021 Q1 | 3.1 Million AUD | -41.1% |
| 2021 Q4 | 7.23 Million AUD | 99.75% |
| 2021 Q2 | 6.25 Million AUD | 101.36% |
| 2021 Q3 | 3.62 Million AUD | -42.05% |
| 2020 Q1 | 2.28 Million AUD | 0.0% |
| 2020 Q2 | 4.55 Million AUD | 99.46% |
| 2020 Q4 | 5.27 Million AUD | 101.82% |
| 2020 Q3 | 2.61 Million AUD | -42.68% |
| 2020 FY | 9.82 Million AUD | 53.89% |
| 2019 FY | 6.38 Million AUD | 52.95% |
| 2018 FY | 4.17 Million AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AdAlta Limited | 6.76 Million AUD | -731.779% |
| Biome Australia Limited | 7.91 Million AUD | -611.74% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -18717.531% |
| Biotron Limited | 5.11 Million AUD | -1001.759% |
| Acrux Limited | 8.55 Million AUD | -558.565% |
| Alterity Therapeutics Limited | 23.4 Million AUD | -140.561% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -9256.173% |
| BTC Health Limited | -1.03 Million AUD | 5519.757% |
| Chimeric Therapeutics Limited | 19.76 Million AUD | -184.85% |
| CSL Limited | 7.56 Billion AUD | 99.255% |
| Clinuvel Pharmaceuticals Limited | 31.29 Million AUD | -79.913% |
| Immutep Limited | 42.87 Million AUD | -31.328% |
| Memphasys Limited | 3.67 Million AUD | -1430.763% |
| Neuren Pharmaceuticals Limited | 32.69 Million AUD | -72.209% |
| Noxopharm Limited | 7 Million AUD | -704.368% |
| Prescient Therapeutics Limited | 10.89 Million AUD | -416.639% |
| Race Oncology Limited | 14.77 Million AUD | -281.215% |
| Starpharma Holdings Limited | 22.81 Million AUD | -146.789% |
| Tissue Repair Ltd | 6.66 Million AUD | -744.592% |
| EZZ Life Science Holdings Limited | 39.57 Million AUD | -42.282% |
| Anatara Lifesciences Ltd | 710.21 Thousand AUD | -7828.186% |
| Bio-Gene Technology Limited | 2.76 Million AUD | -1939.371% |
| Zelira Therapeutics Limited | 5.94 Million AUD | -846.578% |
| Patrys Limited | 4.93 Million AUD | -1041.369% |
| Orthocell Limited | 15.36 Million AUD | -266.357% |
| Imugene Limited | 135.09 Million AUD | 58.319% |
| PYC Therapeutics Limited | 60.91 Million AUD | 7.566% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | -6211.468% |
| Cynata Therapeutics Limited | 11.12 Million AUD | -406.198% |
| Arovella Therapeutics Limited | 10.78 Million AUD | -422.076% |
| Nanollose Limited | 12.5 Thousand AUD | -450322.542% |
| Invex Therapeutics Ltd | 3.34 Million AUD | -1582.884% |
| NeuroScientific Biopharmaceuticals Limited | 1.96 Million AUD | -2765.19% |
| Amplia Therapeutics Limited | 8.43 Million AUD | -567.487% |
| Island Pharmaceuticals Limited | 4.12 Million AUD | -1264.908% |
| Nyrada Inc. | 4.55 Million AUD | -1136.12% |
| Telix Pharmaceuticals Limited | 269.26 Million AUD | 79.089% |
| Dimerix Limited | 25.64 Million AUD | -119.579% |
| PharmAust Limited | 6.65 Million AUD | -745.838% |
| Hexima Limited | 1 Million AUD | -5481.891% |
| AnteoTech Limited | 12.18 Million AUD | -362.028% |
| Paradigm Biopharmaceuticals Limited | 65.1 Million AUD | 13.511% |
| Recce Pharmaceuticals Ltd | 21.68 Million AUD | -159.667% |
| Avecho Biotechnology Limited | 4.54 Million AUD | -1138.778% |
| Actinogen Medical Limited | 22.77 Million AUD | -147.282% |
| Immuron Limited | 9.13 Million AUD | -516.194% |
| Argenica Therapeutics Limited | 8.26 Million AUD | -580.933% |